Free Trial

Bright Minds Biosciences (DRUG) Earnings Date, Estimates & Call Transcripts

Bright Minds Biosciences logo
$35.99 -0.16 (-0.44%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$36.04 +0.05 (+0.15%)
As of 02/21/2025 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bright Minds Biosciences Latest Earnings Summary

Actual EPS
(Feb. 13)
$0.01 Beat By $0.24
Consensus EPS
(Feb. 13)
-$0.23

Bright Minds Biosciences announced Q1 2025 earnings on February 13, 2025, reporting an EPS of $0.01, which topped the consensus estimate of -$0.23 by $0.24. With a trailing EPS of -$0.17, Bright Minds Biosciences' earnings are expected to decrease next year, from ($1.33) to ($3.83) per share.

Get Bright Minds Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bright Minds Biosciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DRUG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DRUG Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bright Minds Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20251-$0.73-$0.73-$0.73
Q4 20251-$0.88-$0.88-$0.88
20252-$1.61-$1.61-$1.61
Q1 20261-$0.96-$0.96-$0.96
Q2 20261-$1.27-$1.27-$1.27
Q3 20261-$1.54-$1.54-$1.54
Q4 20261-$1.79-$1.79-$1.79
FY 20264($5.56)($5.56)($5.56)

Bright Minds Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/13/2025Q1 2025-$0.23$0.01+$0.24$0.01--
12/30/2024Q4 2024--$0.12 -$0.12-$0.12--
8/14/2024Q3 2024-$0.04+$0.04$0.04--
5/15/2024Q2 2024--$0.10 -$0.10-$0.10--
2/12/2024Q1 2024--$0.32 -$0.32-$0.32--
12/29/2023Q4 2023--$0.30 -$0.30-$0.30--
8/14/2023Q3 2023--$0.29 -$0.29-$0.29--
5/15/2023Q2 2023--$0.40 -$0.40-$0.08--

Bright Minds Biosciences Earnings - Frequently Asked Questions

Bright Minds Biosciences (NASDAQ:DRUG) last announced its quarterly earning data on Thursday, February 13, 2025. Learn more on DRUG's earnings history.

In the previous quarter, Bright Minds Biosciences (NASDAQ:DRUG) reported $0.01 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.24. Learn more on analysts' earnings estimate vs. DRUG's actual earnings.

Bright Minds Biosciences (NASDAQ:DRUG) has a recorded net income of -$2.06 million. DRUG has generated -$0.17 earnings per share over the last four quarters.

Bright Minds Biosciences's earnings are expected to decrease from ($1.33) per share to ($3.83) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:DRUG) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners